Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Walter Hans Meisen"'
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e72882 (2013)
Glioblastoma is the most aggressive and common type of malignant brain tumor in humans, with a median survival of 15 months. There is a great need for more therapies for the treatment of glioblastoma. Naturally occurring phytochemicals have received
Externí odkaz:
https://doaj.org/article/8834fda3db3f469ab738dbe8634a3a8f
Autor:
Balveen Kaur, Michael C. Ostrowski, Arnab Chakravarti, Kimerly Powell, J. Bradley Elder, Alena Cristina Jaime-Ramirez, Peter Boyer, Norman L. Lehman, Katie Thies, Haritha Mathsyaraja, Steven T. Sizemore, Samuel Dubin, Walter Hans Meisen
Description of western blot methodology for supplemental Figure and sources of gene expression data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24165bb5896ee1236b493be2e426a031
https://doi.org/10.1158/1535-7163.22501980.v1
https://doi.org/10.1158/1535-7163.22501980.v1
Autor:
Balveen Kaur, Michael C. Ostrowski, Arnab Chakravarti, Kimerly Powell, J. Bradley Elder, Alena Cristina Jaime-Ramirez, Peter Boyer, Norman L. Lehman, Katie Thies, Haritha Mathsyaraja, Steven T. Sizemore, Samuel Dubin, Walter Hans Meisen
Supplemental Figure 1: The ability of 34.5ENVE to infect and replicate in DB-7 and Met-1 BC cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3611f151cde10fe1fad85cb05dd463
https://doi.org/10.1158/1535-7163.22501989
https://doi.org/10.1158/1535-7163.22501989
Autor:
Jianfeng Han, Jianhong Chu, Qi-En Wang, Jianying Zhang, Lingling Zhang, Jianhua Yu, Xiaoming He, Xilin Chen, Lichao Chen, Michael A. Caligiuri, Bo Xu, Walter Hans Meisen, E. Antonio Chiocca, Balveen Kaur
Publikováno v:
Cancer Research. 75:5273-5282
Oncolytic viruses, including oncolytic herpes simplex virus (oHSV), have produced provocative therapeutic responses in patients with glioblastoma, the most aggressive brain tumor. Paradoxically, innate immune responses mediated by natural killer (NK)
Autor:
Kimerly A. Powell, Samuel Dubin, Balveen Kaur, Norman L. Lehman, Michael C. Ostrowski, Alena Cristina Jaime-Ramirez, J. Bradley Elder, Arnab Chakravarti, Steven T. Sizemore, Walter Hans Meisen, Haritha Mathsyaraja, Katie A. Thies, Peter Boyer
Publikováno v:
Molecular Cancer Therapeutics. 14:307-314
The 2-year survival rate of patients with breast cancer brain metastases is less than 2%. Treatment options for breast cancer brain metastases are limited, and there is an unmet need to identify novel therapies for this disease. Brain angiogenesis in
Autor:
Amy Haseley Thorne, Luke Russell, Justin D. Lathia, Chelsea Bolyard, Ji Young Yoo, Jianhua Yu, Walter Hans Meisen, Jeremy N. Rich, Balveen Kaur, Hsiaoyin Mao, Vinay K. Puduvalli, Michael A. Caligiuri, Susheela Tridandapani
Publikováno v:
Molecular Therapy. 22:1678-1687
Glioblastoma is a devastating disease, and there is an urgent need to develop novel therapies, such as oncolytic HSV1 (OV) to effectively target tumor cells. OV therapy depends on tumor-specific replication leading to destruction of neoplastic tissue
Autor:
Sherry Thornton, Balveen Kaur, Haritha Mathsyaraja, Zhengtao Chu, Tristan Bourdeau, Mary B. Palascak, Nicholas L Denton, Michael C. Ostrowski, Chang-Hyuk Kwon, Jeffrey Wojton, Lionel M.L. Chow, Walter Hans Meisen, Robert S. Franco, Xiaoyang Qi
Publikováno v:
Molecular Therapy. 21:1517-1525
Saposin C-dioleoylphosphatidylserine (SapC-DOPS) nanovesicles are a nanotherapeutic which effectively target and destroy cancer cells. Here, we explore the systemic use of SapC-DOPS in several models of brain cancer, including glioblastoma multiforme
Autor:
Yue Liu, Mireia Guerau-de-Arellano, Amy E. Lovett-Racke, Michael K. Racke, Walter Hans Meisen, David Pitt
Publikováno v:
Journal of autoimmune disorders. 1(1)
Genetic studies suggest that the immune system is the greatest genetic contributor to multiple sclerosis (MS) susceptibility. Yet, these immune-related genes do not explain why inflammation is limited to the CNS in MS. We hypothesize that there is an
Autor:
Jianying Zhang, Jianhua Yu, Ichiro Nakano, Xiaoming He, Sung Hak Kim, Jianhong Chu, Justus B. Cohen, Joseph C. Glorioso, Balveen Kaur, Aaron R. Victor, Paola Grandi, Youwei Wang, E. Antonio Chiocca, Wing Keung Chan, Michael A. Caligiuri, Jianfeng Han, Qi-En Wang, Walter Hans Meisen
Publikováno v:
Scientific Reports
Glioblastoma (GB) remains the most aggressive primary brain malignancy. Adoptive transfer of chimeric antigen receptor (CAR)-modified immune cells has emerged as a promising anti-cancer approach, yet the potential utility of CAR-engineered natural ki
Publikováno v:
Journal of neuro-oncology. 126(3)
The five-year survival rate for patients with malignant glioma is less than 10%. Despite aggressive chemo/radiotherapy these tumors have remained resistant to almost every interventional strategy evaluated in patients. Resistance to these agents is a